Millennium Management’s Meridian Bioscience Inc VIVO Stock Holding History

Millennium Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,500	Closed	-$515K	–	7402
2022 Q4	$515K	Buy	+15,500	New	+$499K	﹤0.01%	4726

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's VIVO Position: Q1 2023 in Review

Millennium Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 1,118,328 shares — an estimated $37.1M sold.

Millennium Management first reported a position in VIVO in Q2 2013 and held it in 32 quarters. The position peaked at $37.1M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Millennium Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 1,118,328 Meridian Bioscience Inc shares in Q1 2023, an estimated $37.1M.
Millennium Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 32 quarters.
Millennium Management's Meridian Bioscience Inc position peaked at $37.1M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.